Compare VYGR & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VYGR | MYFW |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 226.8M | 255.0M |
| IPO Year | 2015 | 2018 |
| Metric | VYGR | MYFW |
|---|---|---|
| Price | $4.02 | $26.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $17.00 | ★ $24.25 |
| AVG Volume (30 Days) | ★ 375.7K | 31.2K |
| Earning Date | 11-10-2025 | 01-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 391.62 |
| EPS | N/A | ★ 1.28 |
| Revenue | $31,316,000.00 | ★ $95,514,000.00 |
| Revenue This Year | N/A | $15.96 |
| Revenue Next Year | $71.78 | $13.77 |
| P/E Ratio | ★ N/A | $20.65 |
| Revenue Growth | N/A | ★ 19.92 |
| 52 Week Low | $2.65 | $17.10 |
| 52 Week High | $5.96 | $28.00 |
| Indicator | VYGR | MYFW |
|---|---|---|
| Relative Strength Index (RSI) | 46.28 | 62.88 |
| Support Level | $3.89 | $25.82 |
| Resistance Level | $4.19 | $27.15 |
| Average True Range (ATR) | 0.19 | 0.70 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 50.57 | 43.94 |
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.